Jakob Dupont

Jakob Dupont is an accomplished medical professional and consultant with extensive experience in oncology. They served as a Consultant Oncologist and Chief Medical Officer at Gossamer Bio from 2018 to 2021, overseeing significant achievements including a NASDAQ IPO. Currently, Jakob is a Board Observer at OnCusp Therapeutics, and holds various roles on the boards of multiple biotechnology companies, including Avenzo Therapeutics and Pyxis Oncology. They have also held positions at renowned institutions such as Memorial Sloan Kettering Cancer Center and Stanford University School of Medicine, where they contributed to advancements in cancer treatment. Jakob is pursuing further educational opportunities in medical oncology and internal medicine.